CTLA4 and neoplasm: To confirm the synergistic anti-tumor activity of adding the anti-CTLA-4 antibody to the combination of anti-PD-1 antibody and B. longum 420, we next performed further animal studies using the Renca-bearing BALB/c mouse RCC syngeneic tumor model.